 | • レポートコード：QYR2104Z5759 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、腫瘍マーカー検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生化学マーカー、癌遺伝子、成長因子、ホルモン、コロニー刺激因子、リンホカイン、免疫組織化学染色、その他）、用途別市場規模（病院、商業/民間研究所、診療所/グループ診療所、がんクリニック、外来診療センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腫瘍マーカー検査の市場動向 ・企業の競争状況、市場シェア ・腫瘍マーカー検査の種類別市場規模（生化学マーカー、癌遺伝子、成長因子、ホルモン、コロニー刺激因子、リンホカイン、免疫組織化学染色、その他） ・腫瘍マーカー検査の用途別市場規模（病院、商業/民間研究所、診療所/グループ診療所、がんクリニック、外来診療センター） ・腫瘍マーカー検査の北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍マーカー検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍マーカー検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍マーカー検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍マーカー検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Diagnostics、Affymetrix、Agilent Technologies、Beckman，Dickinson（BD）、BioCurex、BioModa、Clarient、Correlogic Systems、Epigenomics、Hologic、Roche Diagnostics） ・結論 |
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease.
During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.
Market Analysis and Insights: Global Tumor Marker Testing Market
The global Tumor Marker Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Marker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Marker Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Marker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Marker Testing market.
Global Tumor Marker Testing Scope and Market Size
Tumor Marker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Marker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Biochemical Markers
Oncogenes
Growth Factors
Hormones
Colony Stimulating Factors
Lymphokines
Immunohistochemical Stains
Others
Segment by Application
Hospitals
Commercial/Private Laboratories
Physician Offices/Group Practices
Cancer Clinics
Ambulatory Care Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Diagnostics
Affymetrix
Agilent Technologies
Beckman，Dickinson（BD）
BioCurex
BioModa
Clarient
Correlogic Systems
Epigenomics
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Marker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biochemical Markers
1.2.3 Oncogenes
1.2.4 Growth Factors
1.2.5 Hormones
1.2.6 Colony Stimulating Factors
1.2.7 Lymphokines
1.2.8 Immunohistochemical Stains
1.2.9 Others
1.3 Market by Application
1.3.1 Global Tumor Marker Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Commercial/Private Laboratories
1.3.4 Physician Offices/Group Practices
1.3.5 Cancer Clinics
1.3.6 Ambulatory Care Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tumor Marker Testing Market Perspective (2016-2027)
2.2 Tumor Marker Testing Growth Trends by Regions
2.2.1 Tumor Marker Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tumor Marker Testing Historic Market Share by Regions (2016-2021)
2.2.3 Tumor Marker Testing Forecasted Market Size by Regions (2022-2027)
2.3 Tumor Marker Testing Industry Dynamic
2.3.1 Tumor Marker Testing Market Trends
2.3.2 Tumor Marker Testing Market Drivers
2.3.3 Tumor Marker Testing Market Challenges
2.3.4 Tumor Marker Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tumor Marker Testing Players by Revenue
3.1.1 Global Top Tumor Marker Testing Players by Revenue (2016-2021)
3.1.2 Global Tumor Marker Testing Revenue Market Share by Players (2016-2021)
3.2 Global Tumor Marker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tumor Marker Testing Revenue
3.4 Global Tumor Marker Testing Market Concentration Ratio
3.4.1 Global Tumor Marker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Marker Testing Revenue in 2020
3.5 Tumor Marker Testing Key Players Head office and Area Served
3.6 Key Players Tumor Marker Testing Product Solution and Service
3.7 Date of Enter into Tumor Marker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tumor Marker Testing Breakdown Data by Type
4.1 Global Tumor Marker Testing Historic Market Size by Type (2016-2021)
4.2 Global Tumor Marker Testing Forecasted Market Size by Type (2022-2027)
5 Tumor Marker Testing Breakdown Data by Application
5.1 Global Tumor Marker Testing Historic Market Size by Application (2016-2021)
5.2 Global Tumor Marker Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Tumor Marker Testing Market Size (2016-2027)
6.2 North America Tumor Marker Testing Market Size by Type
6.2.1 North America Tumor Marker Testing Market Size by Type (2016-2021)
6.2.2 North America Tumor Marker Testing Market Size by Type (2022-2027)
6.2.3 North America Tumor Marker Testing Market Size by Type (2016-2027)
6.3 North America Tumor Marker Testing Market Size by Application
6.3.1 North America Tumor Marker Testing Market Size by Application (2016-2021)
6.3.2 North America Tumor Marker Testing Market Size by Application (2022-2027)
6.3.3 North America Tumor Marker Testing Market Size by Application (2016-2027)
6.4 North America Tumor Marker Testing Market Size by Country
6.4.1 North America Tumor Marker Testing Market Size by Country (2016-2021)
6.4.2 North America Tumor Marker Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Tumor Marker Testing Market Size (2016-2027)
7.2 Europe Tumor Marker Testing Market Size by Type
7.2.1 Europe Tumor Marker Testing Market Size by Type (2016-2021)
7.2.2 Europe Tumor Marker Testing Market Size by Type (2022-2027)
7.2.3 Europe Tumor Marker Testing Market Size by Type (2016-2027)
7.3 Europe Tumor Marker Testing Market Size by Application
7.3.1 Europe Tumor Marker Testing Market Size by Application (2016-2021)
7.3.2 Europe Tumor Marker Testing Market Size by Application (2022-2027)
7.3.3 Europe Tumor Marker Testing Market Size by Application (2016-2027)
7.4 Europe Tumor Marker Testing Market Size by Country
7.4.1 Europe Tumor Marker Testing Market Size by Country (2016-2021)
7.4.2 Europe Tumor Marker Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Tumor Marker Testing Market Size (2016-2027)
8.2 Asia-Pacific Tumor Marker Testing Market Size by Type
8.2.1 Asia-Pacific Tumor Marker Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tumor Marker Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tumor Marker Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Tumor Marker Testing Market Size by Application
8.3.1 Asia-Pacific Tumor Marker Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tumor Marker Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tumor Marker Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Tumor Marker Testing Market Size by Region
8.4.1 Asia-Pacific Tumor Marker Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tumor Marker Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Tumor Marker Testing Market Size (2016-2027)
9.2 Latin America Tumor Marker Testing Market Size by Type
9.2.1 Latin America Tumor Marker Testing Market Size by Type (2016-2021)
9.2.2 Latin America Tumor Marker Testing Market Size by Type (2022-2027)
9.2.3 Latin America Tumor Marker Testing Market Size by Type (2016-2027)
9.3 Latin America Tumor Marker Testing Market Size by Application
9.3.1 Latin America Tumor Marker Testing Market Size by Application (2016-2021)
9.3.2 Latin America Tumor Marker Testing Market Size by Application (2022-2027)
9.3.3 Latin America Tumor Marker Testing Market Size by Application (2016-2027)
9.4 Latin America Tumor Marker Testing Market Size by Country
9.4.1 Latin America Tumor Marker Testing Market Size by Country (2016-2021)
9.4.2 Latin America Tumor Marker Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tumor Marker Testing Market Size (2016-2027)
10.2 Middle East & Africa Tumor Marker Testing Market Size by Type
10.2.1 Middle East & Africa Tumor Marker Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tumor Marker Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tumor Marker Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Tumor Marker Testing Market Size by Application
10.3.1 Middle East & Africa Tumor Marker Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tumor Marker Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tumor Marker Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Tumor Marker Testing Market Size by Country
10.4.1 Middle East & Africa Tumor Marker Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tumor Marker Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Details
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Tumor Marker Testing Introduction
11.1.4 Abbott Diagnostics Revenue in Tumor Marker Testing Business (2016-2021)
11.1.5 Abbott Diagnostics Recent Development
11.2 Affymetrix
11.2.1 Affymetrix Company Details
11.2.2 Affymetrix Business Overview
11.2.3 Affymetrix Tumor Marker Testing Introduction
11.2.4 Affymetrix Revenue in Tumor Marker Testing Business (2016-2021)
11.2.5 Affymetrix Recent Development
11.3 Agilent Technologies
11.3.1 Agilent Technologies Company Details
11.3.2 Agilent Technologies Business Overview
11.3.3 Agilent Technologies Tumor Marker Testing Introduction
11.3.4 Agilent Technologies Revenue in Tumor Marker Testing Business (2016-2021)
11.3.5 Agilent Technologies Recent Development
11.4 Beckman，Dickinson（BD）
11.4.1 Beckman，Dickinson（BD） Company Details
11.4.2 Beckman，Dickinson（BD） Business Overview
11.4.3 Beckman，Dickinson（BD） Tumor Marker Testing Introduction
11.4.4 Beckman，Dickinson（BD） Revenue in Tumor Marker Testing Business (2016-2021)
11.4.5 Beckman，Dickinson（BD） Recent Development
11.5 BioCurex
11.5.1 BioCurex Company Details
11.5.2 BioCurex Business Overview
11.5.3 BioCurex Tumor Marker Testing Introduction
11.5.4 BioCurex Revenue in Tumor Marker Testing Business (2016-2021)
11.5.5 BioCurex Recent Development
11.6 BioModa
11.6.1 BioModa Company Details
11.6.2 BioModa Business Overview
11.6.3 BioModa Tumor Marker Testing Introduction
11.6.4 BioModa Revenue in Tumor Marker Testing Business (2016-2021)
11.6.5 BioModa Recent Development
11.7 Clarient
11.7.1 Clarient Company Details
11.7.2 Clarient Business Overview
11.7.3 Clarient Tumor Marker Testing Introduction
11.7.4 Clarient Revenue in Tumor Marker Testing Business (2016-2021)
11.7.5 Clarient Recent Development
11.8 Correlogic Systems
11.8.1 Correlogic Systems Company Details
11.8.2 Correlogic Systems Business Overview
11.8.3 Correlogic Systems Tumor Marker Testing Introduction
11.8.4 Correlogic Systems Revenue in Tumor Marker Testing Business (2016-2021)
11.8.5 Correlogic Systems Recent Development
11.9 Epigenomics
11.9.1 Epigenomics Company Details
11.9.2 Epigenomics Business Overview
11.9.3 Epigenomics Tumor Marker Testing Introduction
11.9.4 Epigenomics Revenue in Tumor Marker Testing Business (2016-2021)
11.9.5 Epigenomics Recent Development
11.10 Hologic
11.10.1 Hologic Company Details
11.10.2 Hologic Business Overview
11.10.3 Hologic Tumor Marker Testing Introduction
11.10.4 Hologic Revenue in Tumor Marker Testing Business (2016-2021)
11.10.5 Hologic Recent Development
11.11 Roche Diagnostics
11.11.1 Roche Diagnostics Company Details
11.11.2 Roche Diagnostics Business Overview
11.11.3 Roche Diagnostics Tumor Marker Testing Introduction
11.11.4 Roche Diagnostics Revenue in Tumor Marker Testing Business (2016-2021)
11.11.5 Roche Diagnostics Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Tumor Marker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biochemical Markers
Table 3. Key Players of Oncogenes
Table 4. Key Players of Growth Factors
Table 5. Key Players of Hormones
Table 6. Key Players of Colony Stimulating Factors
Table 7. Key Players of Lymphokines
Table 8. Key Players of Immunohistochemical Stains
Table 9. Key Players of Others
Table 10. Global Tumor Marker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Tumor Marker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Tumor Marker Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Tumor Marker Testing Market Share by Regions (2016-2021)
Table 14. Global Tumor Marker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Tumor Marker Testing Market Share by Regions (2022-2027)
Table 16. Tumor Marker Testing Market Trends
Table 17. Tumor Marker Testing Market Drivers
Table 18. Tumor Marker Testing Market Challenges
Table 19. Tumor Marker Testing Market Restraints
Table 20. Global Tumor Marker Testing Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Tumor Marker Testing Market Share by Players (2016-2021)
Table 22. Global Top Tumor Marker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Marker Testing as of 2020)
Table 23. Ranking of Global Top Tumor Marker Testing Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Tumor Marker Testing Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Tumor Marker Testing Product Solution and Service
Table 27. Date of Enter into Tumor Marker Testing Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Tumor Marker Testing Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Tumor Marker Testing Revenue Market Share by Type (2016-2021)
Table 31. Global Tumor Marker Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Tumor Marker Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Tumor Marker Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Tumor Marker Testing Revenue Market Share by Application (2016-2021)
Table 35. Global Tumor Marker Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Tumor Marker Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Tumor Marker Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Tumor Marker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Tumor Marker Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Tumor Marker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Tumor Marker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Tumor Marker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Tumor Marker Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Tumor Marker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Tumor Marker Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Tumor Marker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Tumor Marker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Tumor Marker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Tumor Marker Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Tumor Marker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Tumor Marker Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Tumor Marker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Tumor Marker Testing Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Tumor Marker Testing Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Tumor Marker Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Tumor Marker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Tumor Marker Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Tumor Marker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Tumor Marker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Tumor Marker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Tumor Marker Testing Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Tumor Marker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Tumor Marker Testing Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Tumor Marker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Tumor Marker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Tumor Marker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 67. Abbott Diagnostics Company Details
Table 68. Abbott Diagnostics Business Overview
Table 69. Abbott Diagnostics Tumor Marker Testing Product
Table 70. Abbott Diagnostics Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 71. Abbott Diagnostics Recent Development
Table 72. Affymetrix Company Details
Table 73. Affymetrix Business Overview
Table 74. Affymetrix Tumor Marker Testing Product
Table 75. Affymetrix Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 76. Affymetrix Recent Development
Table 77. Agilent Technologies Company Details
Table 78. Agilent Technologies Business Overview
Table 79. Agilent Technologies Tumor Marker Testing Product
Table 80. Agilent Technologies Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 81. Agilent Technologies Recent Development
Table 82. Beckman，Dickinson（BD） Company Details
Table 83. Beckman，Dickinson（BD） Business Overview
Table 84. Beckman，Dickinson（BD） Tumor Marker Testing Product
Table 85. Beckman，Dickinson（BD） Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 86. Beckman，Dickinson（BD） Recent Development
Table 87. BioCurex Company Details
Table 88. BioCurex Business Overview
Table 89. BioCurex Tumor Marker Testing Product
Table 90. BioCurex Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 91. BioCurex Recent Development
Table 92. BioModa Company Details
Table 93. BioModa Business Overview
Table 94. BioModa Tumor Marker Testing Product
Table 95. BioModa Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 96. BioModa Recent Development
Table 97. Clarient Company Details
Table 98. Clarient Business Overview
Table 99. Clarient Tumor Marker Testing Product
Table 100. Clarient Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 101. Clarient Recent Development
Table 102. Correlogic Systems Company Details
Table 103. Correlogic Systems Business Overview
Table 104. Correlogic Systems Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 105. Correlogic Systems Recent Development
Table 106. Epigenomics Company Details
Table 107. Epigenomics Business Overview
Table 108. Epigenomics Tumor Marker Testing Product
Table 109. Epigenomics Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 110. Epigenomics Recent Development
Table 111. Hologic Company Details
Table 112. Hologic Business Overview
Table 113. Hologic Tumor Marker Testing Product
Table 114. Hologic Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 115. Hologic Recent Development
Table 116. Roche Diagnostics Company Details
Table 117. Roche Diagnostics Business Overview
Table 118. Roche Diagnostics Tumor Marker Testing Product
Table 119. Roche Diagnostics Revenue in Tumor Marker Testing Business (2016-2021) & (US$ Million)
Table 120. Roche Diagnostics Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Marker Testing Market Share by Type: 2020 VS 2027
Figure 2. Biochemical Markers Features
Figure 3. Oncogenes Features
Figure 4. Growth Factors Features
Figure 5. Hormones Features
Figure 6. Colony Stimulating Factors Features
Figure 7. Lymphokines Features
Figure 8. Immunohistochemical Stains Features
Figure 9. Others Features
Figure 10. Global Tumor Marker Testing Market Share by Application: 2020 VS 2027
Figure 11. Hospitals Case Studies
Figure 12. Commercial/Private Laboratories Case Studies
Figure 13. Physician Offices/Group Practices Case Studies
Figure 14. Cancer Clinics Case Studies
Figure 15. Ambulatory Care Centers Case Studies
Figure 16. Tumor Marker Testing Report Years Considered
Figure 17. Global Tumor Marker Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 18. Global Tumor Marker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 19. Global Tumor Marker Testing Market Share by Regions: 2020 VS 2027
Figure 20. Global Tumor Marker Testing Market Share by Regions (2022-2027)
Figure 21. Global Tumor Marker Testing Market Share by Players in 2020
Figure 22. Global Top Tumor Marker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Marker Testing as of 2020
Figure 23. The Top 10 and 5 Players Market Share by Tumor Marker Testing Revenue in 2020
Figure 24. Global Tumor Marker Testing Revenue Market Share by Type (2016-2021)
Figure 25. Global Tumor Marker Testing Revenue Market Share by Type (2022-2027)
Figure 26. North America Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. North America Tumor Marker Testing Market Share by Type (2016-2027)
Figure 28. North America Tumor Marker Testing Market Share by Application (2016-2027)
Figure 29. North America Tumor Marker Testing Market Share by Country (2016-2027)
Figure 30. United States Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Canada Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Europe Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Tumor Marker Testing Market Share by Type (2016-2027)
Figure 34. Europe Tumor Marker Testing Market Share by Application (2016-2027)
Figure 35. Europe Tumor Marker Testing Market Share by Country (2016-2027)
Figure 36. Germany Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. France Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. U.K. Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Italy Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Russia Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Nordic Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Asia-Pacific Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Tumor Marker Testing Market Share by Type (2016-2027)
Figure 44. Asia-Pacific Tumor Marker Testing Market Share by Application (2016-2027)
Figure 45. Asia-Pacific Tumor Marker Testing Market Share by Region (2016-2027)
Figure 46. China Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Japan Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. South Korea Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Southeast Asia Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. India Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Australia Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Latin America Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Tumor Marker Testing Market Share by Type (2016-2027)
Figure 54. Latin America Tumor Marker Testing Market Share by Application (2016-2027)
Figure 55. Latin America Tumor Marker Testing Market Share by Country (2016-2027)
Figure 56. Mexico Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Brazil Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Middle East & Africa Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Tumor Marker Testing Market Share by Type (2016-2027)
Figure 60. Middle East & Africa Tumor Marker Testing Market Share by Application (2016-2027)
Figure 61. Middle East & Africa Tumor Marker Testing Market Share by Country (2016-2027)
Figure 62. Turkey Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 63. Saudi Arabia Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. UAE Tumor Marker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. Abbott Diagnostics Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 66. Affymetrix Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 67. Agilent Technologies Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 68. Beckman，Dickinson（BD） Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 69. BioCurex Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 70. BioModa Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 71. Clarient Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 72. Correlogic Systems Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 73. Epigenomics Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 74. Hologic Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 75. Roche Diagnostics Revenue Growth Rate in Tumor Marker Testing Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
世界の肝炎マーカー検査市場規模・現状・予測（2021年-2027年） The liver is an essential organ of the body which helps in digestion of food, removal of toxins from the blood, and storage of energy in the body. Inflammation of the liver usually due to viral infections, excessive alcohol consumption, and drugs can cause hepatitis. Hepatitis can be classified as h…- 世界のヘルペスマーカー検査市場規模・現状・予測（2021年-2027年） Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial disea…
- 世界のヘルペスマーカー検査市場規模・現状・予測（2021年-2027年） Herpes marker testing is done to detect the presence of the herpes simplex virus (HSV) infection in the body. Various strains of herpes simplex virus have been known to infect humans. Among these, only two are included in the scope of our study: HSV1 and HSV-2. HSV-1 generally causes orofacial disea…
- 世界の固形腫瘍検査市場規模・現状・予測（2021年-2027年） Solid tumor testing is a medical procedure that helps in the early detection of cancer. It is done to avoid the spread of cancerous cells throughout the body and allow for effective treatment. Hospitals will be the primary end-user to the solid tumor testing market in the global till the end of 2025…
- 世界の固形腫瘍検査市場規模・現状・予測（2021年-2027年） Solid tumor testing is a medical procedure that helps in the early detection of cancer. It is done to avoid the spread of cancerous cells throughout the body and allow for effective treatment. Hospitals will be the primary end-user to the solid tumor testing market in the global till the end of 2025…